Collaboration in Healthcare

We view strategic collaborations as integral to transforming the lives of patients with serious medical needs around the world. Together with our partners, we bring healthcare innovations to life.

Healthcare Innovation Starts with Collaboration

If you're searching for a strong partner for your next project, look no further than Merck KGaA, Darmstadt, Germany. Whether it’s an early-stage licensing opportunity, new technology or strategic research alliance, we’re actively seeking partnerships with like-minded organizations – those that value trust, transparency and mutually rewarding relationships, with the ambition to increase the value of each partnership.We are focused on broadening our access to the world of scientific and product innovation beyond our own laboratories, and are interested in extending our global and regional commercial portfolio. If you are looking for a partner either to bring your competitive portfolio of investigational products to the market, or to fully exploit the potential of your commercial products, we’d love to hear from you.

Learn more about our Strategic Focus & Partnerships

Strategy in Action

In order to achieve our strategic business objectives, we are aiming to invest energy and resources in the following partnerships, key franchises and markets.

Building our Bench Strength

For further information in partnering with us, please visit here.

We believe in the innovative power of collaboration. We are actively seeking new strategic partnerships, and will consider all opportunities that have the potential to create value using innovative deal structures and creative alliances. Take a deeper dive into our key areas and partnerships.

Learn more about collaborating with us

Accelerating innovation

We are committed to a collaborative R&D model, forging partnerships with academic, research institutions, and biotech and pharma companies to bring new therapies to patients. With roughly 50% of our pipeline developed through collaborations, we value the innovative spirit that exists both inside our walls and around the ecosystem of healthcare.

Related News

View All News
  1. Press Releases

    Merck KGaA, Darmstadt, Germany Enters Collaboration and Option to License Agreement ...

    Merck KGaA, Darmstadt, Germany, today announced a collaboration agreement with licensing option with Nerviano Medical Sciences S.r.l. (NMS).

    2022/09/21

  2. Press Releases

    Merck KGaA, Darmstadt, Germany, to Highlight Data at ESMO 2022 with Potential ...

    Merck KGaA, Darmstadt, Germany today announced the latest research from the Company’s oncology portfolio and pipeline to be presented at this year’s European Society of Medical Oncology (ESMO) Annual Meeting.

    2022/09/08

  3. Press Releases

    Xevinapant Five-Year Data Show Survival Rate Nearly Doubled in Patients With ...

    Merck KGaA, Darmstadt, Germany today announced that the IAP (inhibitor of apoptosis protein) inhibitor xevinapant (formerly known as Debio 1143) plus chemoradiotherapy (CRT) markedly improved long-term ...

    2022/09/08